N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine

C202H158N20 — CID 159696511

IUPACN,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine
SMILESC.C.C.C.C.Cc1cc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cnc1-c1ccc(-c2nc3ccccc3n2-c2ccccc2)nc1.c1ccc(N(c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)c2ccc3ccccc3c2)cc1.c1ccc(N(c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)c2cccc3ccccc23)cc1.c1ccc(N(c2ccccc2)c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)cc1
InChIInChI=1S/2C51H35N5.C48H35N5.C47H33N5.5CH4/c1-3-14-42(15-4-1)55(49-21-11-13-39-12-7-8-18-45(39)49)44-30-26-37(27-31-44)36-22-24-38(25-23-36)40-28-32-46(52-34-40)41-29-33-48(53-35-41)51-54-47-19-9-10-20-50(47)56(51)43-16-5-2-6-17-43;1-3-13-43(14-4-1)55(46-30-25-36-11-7-8-12-40(36)33-46)45-28-23-38(24-29-45)37-19-21-39(22-20-37)41-26-31-47(52-34-41)42-27-32-49(53-35-42)51-54-48-17-9-10-18-50(48)56(51)44-15-5-2-6-16-44;1-34-31-39(33-50-47(34)38-27-30-45(49-32-38)48-51-44-19-11-12-20-46(44)53(48)42-17-9-4-10-18-42)37-23-21-35(22-24-37)36-25-28-43(29-26-36)52(40-13-5-2-6-14-40)41-15-7-3-8-16-41;1-4-12-39(13-5-1)51(40-14-6-2-7-15-40)42-28-24-35(25-29-42)34-20-22-36(23-21-34)37-26-30-43(48-32-37)38-27-31-45(49-33-38)47-50-44-18-10-11-19-46(44)52(47)41-16-8-3-9-17-41;;;;;/h2*1-35H;2-33H,1H3;1-33H;5*1H4
InChIKeyMXBQLNPNIHITRW-UHFFFAOYSA-N
MW2865.63 g/mol
LogP53.61
Rot. Bonds32

About N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine

N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine (PubChem CID 159696511) has the molecular formula C202H158N20 and a molecular weight of 2865.63 g/mol. Its IUPAC name is N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine.

Molecular Properties

Compound NameN,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine
PubChem CID159696511
Molecular FormulaC202H158N20
Molecular Weight2865.63 g/mol
Exact Mass2863.30
IUPAC NameN,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine
SMILESC.C.C.C.C.Cc1cc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cnc1-c1ccc(-c2nc3ccccc3n2-c2ccccc2)nc1.c1ccc(N(c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)c2ccc3ccccc3c2)cc1.c1ccc(N(c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)c2cccc3ccccc23)cc1.c1ccc(N(c2ccccc2)c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)cc1
InChIInChI=1S/2C51H35N5.C48H35N5.C47H33N5.5CH4/c1-3-14-42(15-4-1)55(49-21-11-13-39-12-7-8-18-45(39)49)44-30-26-37(27-31-44)36-22-24-38(25-23-36)40-28-32-46(52-34-40)41-29-33-48(53-35-41)51-54-47-19-9-10-20-50(47)56(51)43-16-5-2-6-17-43;1-3-13-43(14-4-1)55(46-30-25-36-11-7-8-12-40(36)33-46)45-28-23-38(24-29-45)37-19-21-39(22-20-37)41-26-31-47(52-34-41)42-27-32-49(53-35-42)51-54-48-17-9-10-18-50(48)56(51)44-15-5-2-6-16-44;1-34-31-39(33-50-47(34)38-27-30-45(49-32-38)48-51-44-19-11-12-20-46(44)53(48)42-17-9-4-10-18-42)37-23-21-35(22-24-37)36-25-28-43(29-26-36)52(40-13-5-2-6-14-40)41-15-7-3-8-16-41;1-4-12-39(13-5-1)51(40-14-6-2-7-15-40)42-28-24-35(25-29-42)34-20-22-36(23-21-34)37-26-30-43(48-32-37)38-27-31-45(49-33-38)47-50-44-18-10-11-19-46(44)52(47)41-16-8-3-9-17-41;;;;;/h2*1-35H;2-33H,1H3;1-33H;5*1H4
InChIKeyMXBQLNPNIHITRW-UHFFFAOYSA-N
XLogP53.61
TPSA187.36 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds32
Heavy Atoms222
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002865.63
LogP ≤ 553.61
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Analyze N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine?
The IUPAC name of N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine (CID 159696511) is N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine.
What is the SMILES notation for N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine?
The canonical SMILES for N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine is C.C.C.C.C.Cc1cc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cnc1-c1ccc(-c2nc3ccccc3n2-c2ccccc2)nc1.c1ccc(N(c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)c2ccc3ccccc3c2)cc1.c1ccc(N(c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)c2cccc3ccccc23)cc1.c1ccc(N(c2ccccc2)c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6nc7ccccc7n6-c6ccccc6)nc5)nc4)cc3)cc2)cc1.
What is the InChIKey of N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine?
The InChIKey is MXBQLNPNIHITRW-UHFFFAOYSA-N. The full InChI is InChI=1S/2C51H35N5.C48H35N5.C47H33N5.5CH4/c1-3-14-42(15-4-1)55(49-21-11-13-39-12-7-8-18-45(39)49)44-30-26-37(27-31-44)36-22-24-38(25-23-36)40-28-32-46(52-34-40)41-29-33-48(53-35-41)51-54-47-19-9-10-20-50(47)56(51)43-16-5-2-6-17-43;1-3-13-43(14-4-1)55(46-30-25-36-11-7-8-12-40(36)33-46)45-28-23-38(24-29-45)37-19-21-39(22-20-37)41-26-31-47(52-34-41)42-27-32-49(53-35-42)51-54-48-17-9-10-18-50(48)56(51)44-15-5-2-6-16-44;1-34-31-39(33-50-47(34)38-27-30-45(49-32-38)48-51-44-19-11-12-20-46(44)53(48)42-17-9-4-10-18-42)37-23-21-35(22-24-37)36-25-28-43(29-26-36)52(40-13-5-2-6-14-40)41-15-7-3-8-16-41;1-4-12-39(13-5-1)51(40-14-6-2-7-15-40)42-28-24-35(25-29-42)34-20-22-36(23-21-34)37-26-30-43(48-32-37)38-27-31-45(49-33-38)47-50-44-18-10-11-19-46(44)52(47)41-16-8-3-9-17-41;;;;;/h2*1-35H;2-33H,1H3;1-33H;5*1H4.
What are the key properties of N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine?
N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine has a molecular weight of 2865.63 g/mol, XLogP of 53.61, 32 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-diphenyl-4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]aniline;methane;4-[4-[5-methyl-6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]-N,N-diphenylaniline;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-1-amine;N-phenyl-N-[4-[4-[6-[6-(1-phenylbenzimidazol-2-yl)-3-pyridinyl]-3-pyridinyl]phenyl]phenyl]naphthalen-2-amine is sourced from PubChem (CID 159696511), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).